Edwards Lifesciences Income Tax Expense Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 135.39  1.14  0.85%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Income Tax Expense of Edwards Lifesciences Corporation with missing and latest data points interpolated. Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Income Tax Expense  10 Years Trend  
Increasing
Slightly volatile
 Income Tax Expense 
      Timeline 

Edwards Lifesciences Income Tax Expense Over Time

2016-12-31  168,400,000 
2017-12-31  168,400,000 
2018-12-31  155,736,842 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  109,072,065
Geometric Mean  68,766,264
Coefficient Of Variation  79.69
Mean Deviation  64,708,377
Median  96,700,000
Standard Deviation  86,918,652
Range  331,400,000
R Value  0.72
R Squared  0.51
Significance  0.005816
Slope  16,001,215

Currently Trending

V   
 NYQ 
Sold over 20 shares of
a day ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
a day ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
a day ago ago
Traded for 10.61